Professor Nada Hamad is a senior haematologist, clinician-researcher, and academic leader with expertise in bone marrow transplantation and cellular therapies. She is the current President of the Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) society and a 2025 Fulbright Senior Scholar.

Her research focuses on improving access and outcomes in advanced therapies, including CAR-T and allogeneic transplant, with a strong emphasis on equity, real-world data, and health system innovation. She leads national and international collaborations that integrate clinical care, research, and policy to address disparities in complex care.

Prof Hamad supervises ILP, Honours, and HDR students across projects spanning translational haematology, equity in access to care, and system-level reform. She is committed to mentorship, capacity building, and supporting the next generation of clinician-scientists.

Her work is supported through government, philanthropic, and industry partnerships aimed at driving meaningful change in health outcomes and health equity.